Peers of MoonLake Immunotherapeutics (MLTX)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by free cash flow over the last 12 months. Values the whole business on the cash it generates.
Latest EV/FCF
-2.65x
As of Oct 22, 2026
Beyond EV/FCF, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/FCF |
|---|---|
| Oct 22, 2026 | -2.65x |
| Oct 21, 2026 | -2.01x |
| Oct 20, 2026 | -1.89x |
| Oct 19, 2026 | -1.68x |
| Oct 16, 2026 | -1.60x |
| Oct 15, 2026 | -1.87x |
| Oct 14, 2026 | -1.82x |
| Oct 13, 2026 | -1.92x |
EV/FCF = Enterprise Value / Free Cash Flow (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/FCF is especially insightful for capital-intensive businesses.
Read the general EV/FCF definition, formula, and analyst usage guide.
EV/FCF guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison